IRIS Institutional Research Information System - OPENBS Open Archive UniBS

METRA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 85.495
AS - Asia 57.541
EU - Europa 46.177
SA - Sud America 12.414
AF - Africa 1.334
OC - Oceania 125
Continente sconosciuto - Info sul continente non disponibili 90
AN - Antartide 2
Totale 203.178
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 84.027
SG - Singapore 19.225
CN - Cina 18.913
UA - Ucraina 10.948
BR - Brasile 10.444
HK - Hong Kong 7.754
IT - Italia 7.387
RU - Federazione Russa 5.395
DE - Germania 5.167
PL - Polonia 3.683
FR - Francia 3.611
VN - Vietnam 3.437
FI - Finlandia 3.071
GB - Regno Unito 2.576
TR - Turchia 2.352
IN - India 2.126
IE - Irlanda 1.968
BD - Bangladesh 820
AR - Argentina 744
SE - Svezia 714
CA - Canada 600
MX - Messico 532
IQ - Iraq 491
ID - Indonesia 361
NL - Olanda 360
ZA - Sudafrica 356
EC - Ecuador 325
JP - Giappone 277
SA - Arabia Saudita 262
AT - Austria 255
PK - Pakistan 247
CO - Colombia 219
ES - Italia 217
VE - Venezuela 179
MA - Marocco 172
NG - Nigeria 164
UZ - Uzbekistan 155
KE - Kenya 151
PY - Paraguay 151
CL - Cile 135
CZ - Repubblica Ceca 134
BE - Belgio 127
QA - Qatar 119
AU - Australia 113
EG - Egitto 105
TN - Tunisia 103
AE - Emirati Arabi Uniti 90
PE - Perù 89
MU - Mauritius 86
JO - Giordania 85
UY - Uruguay 80
NP - Nepal 78
PH - Filippine 78
EU - Europa 76
IL - Israele 70
MY - Malesia 63
RO - Romania 63
LT - Lituania 60
JM - Giamaica 57
IR - Iran 54
KR - Corea 54
AZ - Azerbaigian 53
DZ - Algeria 50
KZ - Kazakistan 50
PA - Panama 48
EE - Estonia 47
ET - Etiopia 47
AL - Albania 45
TT - Trinidad e Tobago 45
HN - Honduras 44
OM - Oman 42
DO - Repubblica Dominicana 41
CH - Svizzera 40
BO - Bolivia 37
LB - Libano 36
TH - Thailandia 36
TW - Taiwan 35
PT - Portogallo 33
BG - Bulgaria 32
NO - Norvegia 31
PS - Palestinian Territory 29
SN - Senegal 28
GR - Grecia 26
HU - Ungheria 26
CR - Costa Rica 25
LV - Lettonia 25
BH - Bahrain 22
KG - Kirghizistan 22
RS - Serbia 21
SC - Seychelles 20
SK - Slovacchia (Repubblica Slovacca) 19
SY - Repubblica araba siriana 17
MK - Macedonia 15
NI - Nicaragua 15
DK - Danimarca 14
MD - Moldavia 13
XK - ???statistics.table.value.countryCode.XK??? 13
KW - Kuwait 12
AM - Armenia 11
BB - Barbados 11
Totale 202.931
Salva come PNG Salva come JPEG
Città #
Singapore 9.974
Fairfield 8.128
Jacksonville 8.000
Hong Kong 7.718
Ashburn 6.885
Woodbridge 6.024
Houston 4.198
Chandler 4.079
Moscow 4.049
The Dalles 3.751
Beijing 3.711
Warsaw 3.611
Cambridge 3.590
Princeton 3.515
Wilmington 3.437
Ann Arbor 3.254
Seattle 3.110
San Jose 3.022
Nanjing 2.769
New York 2.074
Dublin 1.949
Lauterbourg 1.883
Istanbul 1.842
Helsinki 1.505
Los Angeles 1.484
Ho Chi Minh City 1.221
Nanchang 1.039
Milan 945
Buffalo 937
São Paulo 872
Des Moines 825
Shenyang 684
Hanoi 667
Hebei 661
Redondo Beach 626
Changsha 614
Tianjin 542
Munich 526
San Diego 508
Dallas 496
Council Bluffs 469
Brescia 468
Jiaxing 458
Shanghai 419
Jinan 411
Chicago 392
Rome 376
Dearborn 375
Rio de Janeiro 340
London 337
Orem 337
San Francisco 333
Boardman 322
Kunming 321
Hangzhou 317
Frankfurt am Main 273
Santa Clara 271
Kocaeli 247
Nuremberg 243
Chennai 241
Verona 239
Tokyo 238
Belo Horizonte 235
Guangzhou 221
Romola 221
Brooklyn 196
Zhengzhou 196
Mexico City 194
Toronto 191
Brasília 172
Turku 171
Montreal 164
Lancaster 163
Curitiba 158
Johannesburg 158
Atlanta 151
Lappeenranta 148
Pune 148
Abuja 146
Dhaka 144
Ningbo 140
Tashkent 140
Porto Alegre 138
Lanzhou 134
Baghdad 132
Haiphong 132
Da Nang 130
Boston 128
Manchester 126
Salvador 126
Nairobi 125
Denver 121
Stockholm 121
Dong Ket 120
Doha 119
Phoenix 119
Campinas 113
Amsterdam 112
Brussels 112
Vienna 111
Totale 127.828
Salva come PNG Salva come JPEG
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis 3.372
Un caso di Sindrome di Bland-White-Garland: origine anomala dell’arteria coronaria sinistra dall’arteria polmonare. 725
Effect of nesiritide in patients with acute decompensated heart failure. 511
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 466
American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). 411
Inodilatatori: perché e quali. 405
Farmaci inotropi non digitalici. 385
La cardiomioplastica dinamica come trattamento della cardiomiopatia dilatativa ingravescente. 361
Livelli circolanti del marcatore tumorale CA 125 in pazienti con scompenso cardiaco cronico:relazione con la classe NYHA, i parametri ecocardiografici e variazioni indotte dalla terapia. 360
Il genotipo DD per il gene dell’enzima di conversione dell’angiotensina identifica i pazienti con insufficienza cardiaca che possono beneficiare di dosi medio elevate di ACE inibitori. 339
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 333
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. 332
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European society of cardiology and endorsed by the European society of intensive care medicine 328
Can we improve the treatment of congestion in heart failure? 296
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial 291
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure 285
Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the protect pilot study 284
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 281
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 277
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. 266
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure 263
Old and new intravenous inotropic agents in the treatment of advanced heart failure 257
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? 256
I polimorfismi Arg16Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca 255
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 255
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 253
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. 250
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation 242
May 2020 at a glance: ischaemic heart failure and sex-related differences 237
L’ indice di performance miocardica ( MPI ) è un importante indicatore prognostico nei pazienti affetti da insufficienza cardiaca cronica. 236
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. 234
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study 234
I polimorfismi Arg16 Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca. 232
Postdischarge assessment after a heart failure hospitalization: the next step forward. 232
Highlights of the 2009 scientific sessions of the European Society of Cardiology. 223
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study 221
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. 219
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release. 214
Effects of serelaxin in patients with acute heart failure 210
Sindromi coronariche acute: ruolo dell’infezione cronica da Helicobacter Pylori e Citomegalovirus. 208
Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. 208
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. 207
Characteristics and mid-term follow-up of a single-center population affected by Tako-Tsubo cardiomyopathy 206
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison 206
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Societyof Cardiology 203
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 202
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 198
Task Force sullo Scompenso Cardiaco Acuto della Societa Europea di Cardiologia. Versione italiana a cura di A Gavazzi, M Metra. Riassunto esecutivo delle linee guida sulla diagnosi e trattamento dello scompenso cardiaco acuto. 195
Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction 195
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 195
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 194
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 193
A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. 192
Efficacia di un nuovo diuretico, la muzolimina, in pazienti con insufficienza cardiaca. 191
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 191
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. 191
Effects of the Adenosine A(1) Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure an Renal Dysfunction Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A(1) Adenosine ReceptorAntagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function) 191
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. 190
Determinazione dell’equilibrio simpato-vagale attraverso l’analisi spettrale della variabilità della frequenza cardiaca in pazienti con insufficienza cardiaca di diverso grado di severità. 189
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 187
A case of iatrogenic severe mitral regurgitation 184
Effetti cardiovascolari della ventilazione servo-adattativa (ASV) in pazienti affetti da apnee notturne e scompenso cardiaco cronico con disfunzione sistolica ventricolare sinistra 184
Amino acids and derivatives, a new treatment of chronic heart failure? 183
Global epidemiology of heart failure 182
Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results 181
Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: Early and midterm outcomes 181
Effectiveness of MitraClip therapy in patients with refractory heart failure 180
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 179
A drastic complex atheromatous aorta. A case report. 178
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 178
Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure. 175
Can we prevent or treat renal dysfunction in acute heart failure? 174
An unusual case of myocardial infarction 173
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients 173
Agents with vasodilator properties in acute heart failure: how to design successful trials 173
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 173
ESC Committe for Practice Guideline (CPG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. 171
Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry 171
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 171
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 170
A rationale for the use of BETA-blockers as standard treatment for heart failure 170
January 2017 at a glance: oncology, diabetes and antidiabetic treatment, pulmonary hypertension 170
Neurohormonal activation in acute heart failure: results from VERITAS 169
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 168
Are Beta-1 and alpha2c-adrenergic receptor polymorphisms associated with an increased risk of heart failure in Caucasian subjects: results of a case-control study 168
Clinical trials update from the World Congress of Cardiology 2006. 167
Beta- adrenergic receptors polymorphisms and response to CRT 166
Effect of High dose of atorvastatin versus moderate dose on endothelial function and inflammatory biomarkers in patients with STEMI 162
Hyponatremia and long-term outcomes in chronic heart failure--an observational study from the Duke Databank for Cardiovascular Diseases. 161
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 161
Heart failure in elderly patients: distinctive features and unresolved issues 160
Is there a rationale for antiplatelet therapy in acute heart failure? 160
EkoSonic Endovascular System for patients with acute pulmonary embolism and contraindication to systemic fibrinolysis 160
EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) 159
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 159
Anemia and heart failure : a cause of progression or only a consequence? 158
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 158
Different types of tricuspid flail: Case reports and review of the literature 158
High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction 158
1Beta-2 adrenergic receptors gene polymorphisms influence the effects of carvedilol in the patients with heart failure. 157
Totale 25.746
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.028.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.028.215
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.901 0 0 0 0 0 0 0 0 0 2.018 2.168 715
2021/202211.528 453 2.281 230 766 247 621 378 981 646 1.315 1.114 2.496
2022/202312.157 1.997 251 132 995 1.079 3.563 47 1.195 1.745 107 505 541
2023/202412.855 752 279 742 837 523 1.817 460 472 3.495 340 741 2.397
2024/202533.663 983 971 811 3.719 3.830 2.485 2.772 1.475 2.820 2.920 6.446 4.431
2025/202658.660 5.959 9.470 5.066 9.586 4.792 3.839 8.793 2.945 4.027 4.183 0 0
Totale 205.157